Finding better ways to screen high-risk Black women for lung cancer
Official title: Evaluating the Feasibility of Lung Cancer Screening in High-Risk Black Women
Funded at Massachusetts General Hospital · NIH-10893382 · Data updated 2026-11-12
This study is looking at how we can better screen Black women who are at high risk for lung cancer, even if they don't fit the usual guidelines, by using special low-dose scans to catch the disease earlier and help save lives.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $499,296 |
| NIH project number | 5R18HS029430-02 |
| Project ID | NIH-10893382 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Black women who are considered high-risk for lung cancer but do not currently qualify for screening under existing guidelines.
✕Less likely to help
Patients who are not at high risk for lung cancer or who do not identify as Black women may not receive benefits from this research.
What this research studies
This research investigates how to improve lung cancer screening for Black women who are at high risk but may not meet current screening guidelines. It focuses on using low-dose computed tomography (LDCT) scans, which have been shown to detect lung cancer earlier and reduce mortality rates. The study aims to identify more women who could benefit from screening by evaluating their risk factors and health history. By addressing the gaps in eligibility criteria, the research seeks to enhance early detection of lung cancer and related cardiovascular diseases.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection of lung cancer in high-risk Black women, potentially saving lives and reducing healthcare costs.
How similar studies have gone: Previous studies have shown that LDCT screening can significantly improve early detection of lung cancer, indicating a promising approach for this research.
Where this research is happening
-
Massachusetts General Hospital
Boston, United States Active
Researchers
- Principal investigator: Yang, Chi-Fu — Massachusetts General Hospital
- Study coordinator: Yang, Chi-Fu
Related research
Other NIH-funded projects on the same topics.
-
Digital health strategies to expand lung cancer screening in safety-net clinics
A funded project aims to help low-resource clinics increase the use of lung cancer screening for patients who smoke or are at risk.
-
Integrated approach to lung screening and quitting for African Americans
A multi-level program aims to boost LDCT lung cancer screening uptake and help African American smokers quit, with support from a comprehensive community-focused plan.
-
Population health approach to boost lung cancer screening at community clinics
A large Utah project aims to help community clinics reach more eligible adults to get low-dose CT lung cancer screening.
-
Group-based tobacco treatment for older adults after lung cancer screening
A study tests a group-based tobacco cessation program for older adults who are getting lung cancer screening to help them quit smoking.
-
Personalized Lung Cancer Screening for Veterans
Aimed at improving who gets screened and how lung cancer is diagnosed among Veterans using personalized tools.
-
Proteogenomic framework to improve lung cancer screening with biomarkers
A biomarker-based approach aims to refine LDCT lung cancer screening so more cancers are caught early while reducing unnecessary procedures.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.